These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16061559)

  • 1. Spectrum of splicing errors caused by CHRNE mutations affecting introns and intron/exon boundaries.
    Ohno K; Tsujino A; Shen XM; Milone M; Engel AG
    J Med Genet; 2005 Aug; 42(8):e53. PubMed ID: 16061559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A frameshifting mutation in CHRNE unmasks skipping of the preceding exon.
    Ohno K; Milone M; Shen XM; Engel AG
    Hum Mol Genet; 2003 Dec; 12(23):3055-66. PubMed ID: 14532324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing abnormalities in congenital myasthenic syndromes.
    Ohno K; Engel AG
    Acta Myol; 2005 Oct; 24(2):50-4. PubMed ID: 16550914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome.
    Masuda A; Shen XM; Ito M; Matsuura T; Engel AG; Ohno K
    Hum Mol Genet; 2008 Dec; 17(24):4022-35. PubMed ID: 18806275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synonymous CHRNE mutation responsible for an aberrant splicing leading to congenital myasthenic syndrome.
    Richard P; Gaudon K; Fournier E; Jackson C; Bauché S; Haddad H; Koenig J; Echenne B; Hantaï D; Eymard B
    Neuromuscul Disord; 2007 May; 17(5):409-14. PubMed ID: 17363247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intronic base alteration of the CHRNE gene leading to a congenital myasthenic syndrome.
    Müller JS; Stucka R; Neudecker S; Zierz S; Schmidt C; Huebner A; Lochmüller H; Abicht A
    Neurology; 2005 Aug; 65(3):463-5. PubMed ID: 16087917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5' splice site.
    Martínez-Pizarro A; Dembic M; Pérez B; Andresen BS; Desviat LR
    PLoS Genet; 2018 Apr; 14(4):e1007360. PubMed ID: 29684050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital end-plate acetylcholinesterase deficiency caused by a nonsense mutation and an A-->G splice-donor-site mutation at position +3 of the collagenlike-tail-subunit gene (COLQ): how does G at position +3 result in aberrant splicing?
    Ohno K; Brengman JM; Felice KJ; Cornblath DR; Engel AG
    Am J Hum Genet; 1999 Sep; 65(3):635-44. PubMed ID: 10441569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations causing defective splicing in the human hprt gene.
    Andersson B; Hou SM; Lambert B
    Environ Mol Mutagen; 1992; 20(2):89-95. PubMed ID: 1380458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndrome.
    Bian Y; Masuda A; Matsuura T; Ito M; Okushin K; Engel AG; Ohno K
    Hum Mol Genet; 2009 Apr; 18(7):1229-37. PubMed ID: 19147685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective pre-mRNA splicing in PKD1 due to presumed missense and synonymous mutations causing autosomal dominant polycystic disease.
    Gonzalez-Paredes FJ; Ramos-Trujillo E; Claverie-Martin F
    Gene; 2014 Aug; 546(2):243-9. PubMed ID: 24907393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection.
    Sakai N; Santamarina-Fojo S; Yamashita S; Matsuzawa Y; Brewer HB
    J Lipid Res; 1996 Oct; 37(10):2065-73. PubMed ID: 8906584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identical G+1 to A mutations in three different introns of the type III procollagen gene (COL3A1) produce different patterns of RNA splicing in three variants of Ehlers-Danlos syndrome. IV. An explanation for exon skipping some mutations and not others.
    Kuivaniemi H; Kontusaari S; Tromp G; Zhao MJ; Sabol C; Prockop DJ
    J Biol Chem; 1990 Jul; 265(20):12067-74. PubMed ID: 2365710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two mutations remote from an exon/intron junction in the beta-hexosaminidase beta-subunit gene affect 3'-splice site selection and cause Sandhoff disease.
    Fujimaru M; Tanaka A; Choeh K; Wakamatsu N; Sakuraba H; Isshiki G
    Hum Genet; 1998 Oct; 103(4):462-9. PubMed ID: 9856491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligonucleotide-mediated exon skipping of CHRNA1 pre-mRNA as potential therapy for Congenital Myasthenic Syndromes.
    Tei S; Ishii HT; Mitsuhashi H; Ishiura S
    Biochem Biophys Res Commun; 2015 Jun; 461(3):481-6. PubMed ID: 25888793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel compound heterozygous mutations for lipoprotein lipase deficiency. A G-to-T transversion at the first position of exon 5 causing G154V missense mutation and a 5' splice site mutation of intron 8.
    Ikeda Y; Takagi A; Nakata Y; Sera Y; Hyoudou S; Hamamoto K; Nishi Y; Yamamoto A
    J Lipid Res; 2001 Jul; 42(7):1072-81. PubMed ID: 11441134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection.
    McCullough AJ; Berget SM
    Mol Cell Biol; 1997 Aug; 17(8):4562-71. PubMed ID: 9234714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosinemia type 1--complex splicing defects and a missense mutation in the fumarylacetoacetase gene.
    Rootwelt H; Kristensen T; Berger R; Høie K; Kvittingen EA
    Hum Genet; 1994 Sep; 94(3):235-9. PubMed ID: 8076937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common CHRNE mutation in Brazilian patients with congenital myasthenic syndrome.
    Estephan EP; Sobreira CFDR; Dos Santos ACJ; Tomaselli PJ; Marques W; Ortega RPM; Costa MCM; da Silva AMS; Mendonça RH; Caldas VM; Zambon AA; Abath Neto O; Marchiori PE; Heise CO; Reed UC; Azuma Y; Töpf A; Lochmüller H; Zanoteli E
    J Neurol; 2018 Mar; 265(3):708-713. PubMed ID: 29383513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefinition of exon 7 in the COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a form of osteogenesis imperfecta: influence of intron splice order on outcome of splice-site mutation.
    Schwarze U; Starman BJ; Byers PH
    Am J Hum Genet; 1999 Aug; 65(2):336-44. PubMed ID: 10417276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.